Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Ly2140023 monohydrate, 956385-05-0, Ly-2140023 monohydrate, Pomaglumetad metionilo, We665jb15r, (1r,4s,5s,6s)-4-(l-methionylamino)-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic acid 2,2-dioxide monohydrate
Molecular Formula
C12H20N2O8S2
Molecular Weight
384.4  g/mol
InChI Key
HQMAHCKDJKNYEK-LBMFEJOUSA-N
FDA UNII
WE665JB15R

a potent and selective methionil prodrug of the metabotropic glutamate
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,4S,5S,6S)-4-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-2,2-dioxo-26-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid;hydrate
2.1.2 InChI
InChI=1S/C12H18N2O7S2.H2O/c1-22-3-2-5(13)9(15)14-12(11(18)19)4-23(20,21)8-6(7(8)12)10(16)17;/h5-8H,2-4,13H2,1H3,(H,14,15)(H,16,17)(H,18,19);1H2/t5-,6+,7+,8-,12-;/m0./s1
2.1.3 InChI Key
HQMAHCKDJKNYEK-LBMFEJOUSA-N
2.2 Other Identifiers
2.2.1 UNII
WE665JB15R
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ly2140023 Monohydrate

2.3.2 Depositor-Supplied Synonyms

1. Ly2140023 Monohydrate

2. 956385-05-0

3. Ly-2140023 Monohydrate

4. Pomaglumetad Metionilo

5. We665jb15r

6. (1r,4s,5s,6s)-4-(l-methionylamino)-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic Acid 2,2-dioxide Monohydrate

7. Dtxsid00212944

8. 4-(((2s)-2-amino-4-(methylthio)butanoyl)amino)-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic Acid 2,2-dioxide Hydrate, 1r,4s,5s,6s

9. Pomaglumetadum Methionilum

10. Refchem:175219

11. Dtxcid30135435

12. 2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic Acid, 4-(((2s)-2-amino-4-(methylthio)-1-oxobutyl)amino)-, 2,2-dioxide, Hydrate (1:1), (1r,4s,5s,6s)-

13. 691-416-7

14. Pomaglumetad Methionil [usan]

15. Pomaglumetad Methionil (usan)

16. (1r,4s,5s,6s)-4-((s)-2-amino-4-(methylthio)butanamido)-2-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic Acid 2,2-dioxide Hydrate

17. (1r,4s,5s,6s)-4-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-2,2-dioxo-2lambda6-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic Acid;hydrate

18. Unii-we665jb15r

19. Pomaglumetad Methionil Hydrate

20. Orb1708826

21. Schembl1100180

22. Chembl2105707

23. Dtxsid10241907

24. Pomaglumetad Methionil Monohydrate

25. Akos040735205

26. Hy-105040

27. Cs-0024754

28. D09949

29. Q27292586

30. (1r,4s,5s,6s)-4-(2s-4-methylthio-2-aminobutanonyl)amino-2,2-dioxo-2lambda6-thia- Bicyclo(3.1.0)hexane-4,6-dicarboxylic Acid Monohydrate

31. (1r,4s,5s,6s)-4-(l-methionylamino)-2,2-dioxo-2gamma6-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic Acid-water (1:1)

32. (1r,4s,5s,6s)-4-(l-methionylamino)-2,2-dioxo-2lambda~6~-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic Acid--water (1/1)

33. (1r,4s,5s,6s)-4-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-2,2-dioxo-2

34. E6-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic Acid;hydrate

35. 2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic Acid, 4-(((2s)-2-amino-4-(methylthio)-1- Oxobutyl)amino)-, 2,2-dioxide, Hydrate (1:1), (1r,4s,5s,6s)-

2.4 Create Date
2012-03-21
3 Chemical and Physical Properties
Molecular Weight 384.4 g/mol
Molecular Formula C12H20N2O8S2
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count10
Rotatable Bond Count7
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area199
Heavy Atom Count24
Formal Charge0
Complexity644
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in psychosis and schizophrenia and schizoaffective disorders.


5 Pharmacology and Biochemistry
5.1 Mechanism of Action

LY2140023 is an antipsychotic agent that is a metabotropic glutamate 2/3 receptor agonist. This agent has a new mechanism of action that is efficacious in treating schizophrenia and potentially other neuropsychiatric conditions. Once absorbed, LY2140023 is efficiently hydrolyzed to produce the active mGlu2/3 receptor agonist LY404039. LY404039 and other mGlu2/3 agonists do not directly interact with dopamine or serotonin (5-HT2A) receptors. However, 'functional' 5-HT2A receptor antagonism in the prefrontal cortex may represent a common mechanism shared by clinically effective atypical antipsychotics and mGlu2/3 receptor agonists, and may contribute to the antipsychotic actions of LY2140023.